RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

Search

OFS Capital Corp

Fermé

4.74 3.72

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.37

Max

4.8100000000000005

Chiffres clés

By Trading Economics

Revenu

4.3M

-5.3M

Ventes

-380K

5.9M

P/E

Moyenne du Secteur

19.25

25.743

BPA

0.22

Rendement du dividende

29.57

Marge bénéficiaire

-90.212

Employés

53

EBITDA

609K

-5.3M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+47.06% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

29.57%

3.67%

Date du Prochain Dividende

30 mars 2026

Date du Prochain Détachement de Dividende

20 mars 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-34M

62M

Ouverture précédente

1.02

Clôture précédente

4.74

Score Technique

By Trading Central

Confiance

Neutral Evidence

OFS Capital Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 déc. 2025, 22:20 UTC

Principaux Mouvements du Marché

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 déc. 2025, 17:31 UTC

Principaux Mouvements du Marché

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 déc. 2025, 16:30 UTC

Principaux Mouvements du Marché

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 déc. 2025, 15:19 UTC

Principaux Mouvements du Marché

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 déc. 2025, 15:17 UTC

Principaux Mouvements du Marché

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 déc. 2025, 14:37 UTC

Principaux Mouvements du Marché

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 déc. 2025, 21:13 UTC

Acquisitions, Fusions, Rachats

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 déc. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 déc. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 déc. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 déc. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 déc. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 déc. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 déc. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 déc. 2025, 17:16 UTC

Principaux Mouvements du Marché

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 déc. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 déc. 2025, 17:00 UTC

Acquisitions, Fusions, Rachats

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 déc. 2025, 15:57 UTC

Acquisitions, Fusions, Rachats

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 déc. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 déc. 2025, 15:02 UTC

Principaux Mouvements du Marché

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 déc. 2025, 14:40 UTC

Acquisitions, Fusions, Rachats

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 déc. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 déc. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 déc. 2025, 13:01 UTC

Résultats
Acquisitions, Fusions, Rachats

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 déc. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 déc. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 déc. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 déc. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 déc. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparaison

Variation de prix

OFS Capital Corp prévision

Objectif de Prix

By TipRanks

47.06% hausse

Prévisions sur 12 Mois

Moyen 7 USD  47.06%

Haut 7 USD

Bas 7 USD

Basé sur 1 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

1 ratings

0

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

8.42 / 8.7917Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Neutral Evidence

Long Terme

Bullish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos OFS Capital Corp

OFS Capital Corporation is a business development company specializing in direct and fund investments as well as add-on acquisitions. It provides flexible capital solutions primarily through debt capital and to a lesser extent, minority equity investments serving the needs of U.S.-based middle-market companies across a broad array of industries. It does not invest in operational turnarounds or start-up businesses. For direct, it specializes in debt and structured equity investments, recapitalizations and refinancing, management and leveraged buyouts, acquisition financings, ownership transition, shareholder liquidity events, growth capital, independent sponsor transactions, ESOPs, and minority investments in the lower middle market companies. It invests in the aerospace and defense, business services, consumer products and services, construction & building, durable goods, capital equipment, automotive, food and beverage, healthcare & pharmaceutical, specialty chemicals, transportation cargo and logistics, value added distribution, franchising, and industrial and niche manufacturing sectors. The firm invests in companies based in United States. It seeks to invest between $3 million and $35 million, revenues between $15 million and $300 million, annual EBITDA between $5 million and $50 million, and Enterprise value between $10 million and $500 million. The firm seeks to invest in companies with debt investment values between $5 million and $25 million. The fund uses senior secured, unitranche loans, first-lien, second lien, subordinated/ mezzanine loans, warrants, and preferred equity securities and common equity securities. It prefers to take a minority as well as majority stake in the investments made. It also co-invests with its partners for additional capital.
help-icon Live chat